Perioperative Nivolumab in Resectable NSCLC | NEJM

  Рет қаралды 1,316

NEJM Group

NEJM Group

Күн бұрын

Neoadjuvant nivolumab plus chemotherapy is standard therapy for resectable non-small-cell lung cancer. Whether the addition of adjuvant nivolumab may improve outcomes is unclear.
Research findings are summarized in a new Quick Take video.
To see the full article, follow this link: nej.md/3VaMtbX
#oncology #criticalcare #nejm

Пікірлер: 1
@wohola
@wohola 4 ай бұрын
I love the NEJM quick take!! Please keep it up for all articles!
The Myth of Low-Serotonin & Antidepressants - Dr. Mark Horowitz
30:17
#1 Best AT HOME Test to Find Clogged Arteries
12:23
Dr. Ford Brewer
Рет қаралды 684 М.
МАИНКРАФТ В РЕАЛЬНОЙ ЖИЗНИ!🌍 @Mikecrab
00:31
⚡️КАН АНДРЕЙ⚡️
Рет қаралды 40 МЛН
АЗАРТНИК 4 |СЕЗОН 1 Серия
40:47
Inter Production
Рет қаралды 1,4 МЛН
GIANT Gummy Worm Pt.6 #shorts
00:46
Mr DegrEE
Рет қаралды 32 МЛН
Medical Mystery Solved - A Deficient Diagnosis | NEJM
7:17
NEJM Group
Рет қаралды 21 М.
2023 Best of Lung: Targeted Therapies in Lung Cancer
30:32
Total Health | Oncology
Рет қаралды 13 М.
Lung Cancer | The most COMPREHENSIVE Explanation
34:56
Medicosis Perfectionalis
Рет қаралды 233 М.
Lung Cancer Breakout: Breakthrough treatments for longer life
31:51
Cancer Research Institute
Рет қаралды 20 М.
Lung Cancer Treatment
5:15
Nucleus Medical Media
Рет қаралды 296 М.
Treatment and Management of Non-Small Cell Lung Cancer (NSCLC)
6:05
You and Lung Cancer
Рет қаралды 44 М.
Differences in Small Cell vs Non-Small Cell Lung Cancer
5:44
curetoday
Рет қаралды 13 М.
МАИНКРАФТ В РЕАЛЬНОЙ ЖИЗНИ!🌍 @Mikecrab
00:31
⚡️КАН АНДРЕЙ⚡️
Рет қаралды 40 МЛН